Health inequality in uk

Socioeconomic status[ edit ] Socioeconomic status is both a strong predictor of health, and a key factor underlying health inequities across populations. Poor socioeconomic status has the capacity to profoundly limit the capabilities of an individual or population, manifesting itself through deficiencies in both financial and social capital. In the UK, prior to the institution of the NHS reforms in the early s, it was shown that income was an important determinant of access to healthcare resources.

Health inequality in uk

Multinational pharmaceutical companies neglect the diseases of the tropics, not because the science is impossible but because there Health inequality in uk, in the cold economics of the drugs companies, no market.

There is, of course, a market in the sense that there is a need: But there is no market in the sense that, unlike Viagra, medicines for leishmaniasis are needed by poor people in poor countries.

Pharmaceutical companies judge that they would not get sufficient return on research investment, so why, they ask, should we bother? For the large companies, they feel their investment into research and development would suffer if other companies then simply copy what they produce.

Yet, a lot of the base science and research that the large companies have benefited from has been publicly funded—through university programs, government subsidized research, and other health programs. Privatizing such profits may be acceptable to a certain degree.

However, Jamie Love, an AIDS activist, denies that the pharmaceuticals even own the rights to the drugs in the first place. He points out that many of the anti-retroviral drugs used to treat HIV and AIDS today stem from the government-funded cancer drug research of the s.

The rights to government-created innovations were sold to pharmaceutical companies at low prices … guaranteeing companies like Bristol-Myers Squibb huge returns on investment. Jamie LoveSalon. Economist and director of the Third World NetworkMartin Khor writes, Just as controversial [as patenting living organisms], or even more so, are patents and patent applications relating to plants that have traditionally been used for medicinal and other purposes e.

Many medicines are derived from or based on biochemical compounds originating from plants and biodiversity in the tropical and sub-tropical countries. Much of the knowledge of the use of plants for medical purposes resides with indigenous peoples and local communities.

Scientists and companies from developed countries have been charged with biopiracy when they appropriate the plants or their compounds from the forests as well as the traditional knowledge of the community healers, since patents are often applied for the materials and the knowledge.

Drummond Rennie, from the Journal of the American Medical Associationnoted in a television documentary that Pharmaceuticals, they are a commodity.

But they are not just a commodity. And that gives them altogether a deeper significance. Indeed, I believe that they often forget it completely. Drummond Rennie, transcribed from Dying for Drugs, Channel 4, UK, April 27, However, critics are pointing out that as well as saving lives, they are also taking lives from the poor, especially in the developing world, where, through rich country governments, they have lobbied for policies that will help ensure that their patents are recognized in most countries, thus extending those monopolies on their drugs.

Writer and broadcaster, John Madeley, summarizes a number of concerns raised over the years: Making use of advertising that is inexpensive in comparison to what they pay in industrialized countries, the drug TNCs [Transnational Corporations] use the most persuasive, not to say unethical, methods to persuade the poor to buy their wares.

Extravagant claims are made that would be outlawed in the Western countries.A campaign focussed on raising awareness of Autism in Girls, the lack of suitable diagnostic tools and lack of suitable provision.

Troublesome Science: The Misuse of Genetics and Genomics in Understanding Race (Race, Inequality, and Health) [Rob DeSalle, Ian Tattersall] on metin2sell.com *FREE* shipping on qualifying offers.

It is well established that all humans today, wherever they live, belong to one single species.

Health inequality in uk

Yet even many people who claim to abhor racism take for granted that human “races” have a biological. “Health in infancy and childhood sets the scene for lifelong health, so we view with dismay data from the Department of Health showing that inequality in infant mortality has widened.

In the UK – one of the richest countries in the world – the gap between rich and poor is growing and the problem starts in infancy. The Health Improvement Partnership aims to support the people of Wiltshire to lead happy and healthy lives. This encompasses not only the individually determined factors such as genetic make up and lifestyle but also the wider determinants such as social and community networks and general socio-economic, cultural and environmental conditions.

Aviva to acquire majority shareholding in Neos Ventures. 21 Nov Aviva has agreed to acquire a majority stake in Neos Ventures Ltd “Neos”, the smart technology insurance provider which helps customers to monitor and protect their homes with connected devices.

Health inequalities Current patterns and trends in ill health and death by measures of socio-economic status.

Health equity - Wikipedia